Cargando…
Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
In Mycobacterium tuberculosis, recent genome-wide association studies have identified a novel constellation of mutations that are correlated with high-level drug resistances. Interpreting the functional importance of the new resistance-associated mutations has been complicated, however, by a lack of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479004/ https://www.ncbi.nlm.nih.gov/pubmed/31015328 http://dx.doi.org/10.1128/mBio.00616-19 |
_version_ | 1783413260289048576 |
---|---|
author | Hicks, Nathan D. Carey, Allison F. Yang, Jian Zhao, Yanlin Fortune, Sarah M. |
author_facet | Hicks, Nathan D. Carey, Allison F. Yang, Jian Zhao, Yanlin Fortune, Sarah M. |
author_sort | Hicks, Nathan D. |
collection | PubMed |
description | In Mycobacterium tuberculosis, recent genome-wide association studies have identified a novel constellation of mutations that are correlated with high-level drug resistances. Interpreting the functional importance of the new resistance-associated mutations has been complicated, however, by a lack of experimental validation and a poor understanding of the epistatic factors influencing these correlations, including strain background and programmatic variation in treatment regimens. Here we perform a genome-wide association analysis in a panel of Mycobacterium tuberculosis strains from China to identify variants correlated with resistance to the second-line prodrug ethionamide (ETH). Mutations in a bacterial monooxygenase, Rv0565c, are significantly associated with ETH resistance. We demonstrate that Rv0565c is a novel activator of ETH, independent of the two known activators, EthA and MymA. Clinically prevalent mutations abrogate Rv0565c function, and deletion of Rv0565c confers a consistent fitness benefit on M. tuberculosis in the presence of partially inhibitory doses of ETH. Interestingly, Rv0565c activity affects susceptibility to prothionamide (PTH), the ETH analog used in China, to a greater degree. Further, clinical isolates vary in their susceptibility to both ETH and PTH, to an extent that correlates with the total expression of ETH/PTH activators (EthA, MymA, and Rv0565c). These results suggest that clinical strains considered susceptible to ETH/PTH are not equally fit during treatment due to both Rv0565c mutations and more global variation in the expression of the prodrug activators. |
format | Online Article Text |
id | pubmed-6479004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-64790042019-04-24 Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis Hicks, Nathan D. Carey, Allison F. Yang, Jian Zhao, Yanlin Fortune, Sarah M. mBio Research Article In Mycobacterium tuberculosis, recent genome-wide association studies have identified a novel constellation of mutations that are correlated with high-level drug resistances. Interpreting the functional importance of the new resistance-associated mutations has been complicated, however, by a lack of experimental validation and a poor understanding of the epistatic factors influencing these correlations, including strain background and programmatic variation in treatment regimens. Here we perform a genome-wide association analysis in a panel of Mycobacterium tuberculosis strains from China to identify variants correlated with resistance to the second-line prodrug ethionamide (ETH). Mutations in a bacterial monooxygenase, Rv0565c, are significantly associated with ETH resistance. We demonstrate that Rv0565c is a novel activator of ETH, independent of the two known activators, EthA and MymA. Clinically prevalent mutations abrogate Rv0565c function, and deletion of Rv0565c confers a consistent fitness benefit on M. tuberculosis in the presence of partially inhibitory doses of ETH. Interestingly, Rv0565c activity affects susceptibility to prothionamide (PTH), the ETH analog used in China, to a greater degree. Further, clinical isolates vary in their susceptibility to both ETH and PTH, to an extent that correlates with the total expression of ETH/PTH activators (EthA, MymA, and Rv0565c). These results suggest that clinical strains considered susceptible to ETH/PTH are not equally fit during treatment due to both Rv0565c mutations and more global variation in the expression of the prodrug activators. American Society for Microbiology 2019-04-23 /pmc/articles/PMC6479004/ /pubmed/31015328 http://dx.doi.org/10.1128/mBio.00616-19 Text en Copyright © 2019 Hicks et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Hicks, Nathan D. Carey, Allison F. Yang, Jian Zhao, Yanlin Fortune, Sarah M. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title_full | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title_fullStr | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title_full_unstemmed | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title_short | Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis |
title_sort | bacterial genome-wide association identifies novel factors that contribute to ethionamide and prothionamide susceptibility in mycobacterium tuberculosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479004/ https://www.ncbi.nlm.nih.gov/pubmed/31015328 http://dx.doi.org/10.1128/mBio.00616-19 |
work_keys_str_mv | AT hicksnathand bacterialgenomewideassociationidentifiesnovelfactorsthatcontributetoethionamideandprothionamidesusceptibilityinmycobacteriumtuberculosis AT careyallisonf bacterialgenomewideassociationidentifiesnovelfactorsthatcontributetoethionamideandprothionamidesusceptibilityinmycobacteriumtuberculosis AT yangjian bacterialgenomewideassociationidentifiesnovelfactorsthatcontributetoethionamideandprothionamidesusceptibilityinmycobacteriumtuberculosis AT zhaoyanlin bacterialgenomewideassociationidentifiesnovelfactorsthatcontributetoethionamideandprothionamidesusceptibilityinmycobacteriumtuberculosis AT fortunesarahm bacterialgenomewideassociationidentifiesnovelfactorsthatcontributetoethionamideandprothionamidesusceptibilityinmycobacteriumtuberculosis |